**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 12141-67-2 |Hexasodium dihydrogendodecawolframate | 100 | 412-770-9 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22 41 52/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Risk of serious damage to eyes. Harmful to
aquatic organisms, may cause long-term adverse effects in the aquatic
environment.
Potential Health Effects
Eye:
Causes severe eye irritation and possible injury.
Skin:
May cause skin irritation.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Runoff from
fire control or dilution water may cause pollution.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry
chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 12141-67-2:
United Kingdom, WEL - TWA: (listed as tungsten, soluble compounds
mg/m3 TWA (as W)
United Kingdom, WEL - STEL: (listed as tungsten, soluble compound
3 mg/m3 STEL (as W)
Belgium - TWA: (listed as tungsten, soluble compounds): 1 mg/m3 V
(as W)
Belgium - STEL: (listed as tungsten, soluble compounds): 3 mg/m3
(as W)
Malaysia: (listed as tungsten, soluble compounds): 1 mg/m3 TWA (a
Netherlands: (listed as tungsten, soluble compounds): 1 mg/m3 MAC
W)
Spain: (listed as tungsten, soluble compounds): 1 mg/m3 VLA-ED (a
Spain: (listed as tungsten, soluble compounds): 3 mg/m3 VLA-EC (a
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: white - grey
Odor: Not available.
pH: ca.3 4000g/l aq.sol.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: 4000 g/l (20C)
Specific Gravity/Density:
Molecular Formula: H4Na6O41W12
Molecular Weight: 3004.14
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
None reported..
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, sodium oxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 12141-67-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Hexasodium dihydrogendodecawolframate -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 41 Risk of serious damage to eyes.
R 52/53 Harmful to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
Safety Phrases:
S 22 Do not breathe dust.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 39 Wear eye/face protection.
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 12141-67-2: 1
Canada
CAS# 12141-67-2 is listed on Canada's NDSL List.
CAS# 12141-67-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 12141-67-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 12/14/1999 Revision #3 Date: 5/31/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
6-Amino-2-Naphthoic Acid, 90%
| 11668-47-4 |
|
Zirconium (IV) Oxide, P.A.
| 1314-23-4 |
|
cis-Dichlorodiamineplatinum(II), 99.99%
| 15663-27-1 |
|
1-Bromonaphthalene 96%, contains max. 2% 2-bromonaphthalene
| 90-11-9 |
|
1-Heptanesulfonic acid, sodium salt, monohydrate, HPLC grade
| 207300-90-1 |
|
1-Hexanesulfonic acid sodium salt, HPLC grade
| 2832-45-3 |
|
5-Bromo-1-pentene, 96%
| 1119-51-3 |
|
2,6-Diphenylphenol
| 2432-11-3 |
|
L-Cystine
| 56-89-3 |
|
1-Pentanesulfonic Acid, Sodium Salt Monohydrate, HPLC Grade
| 22767-49-3 |
|
1,1,2-Trichloroethane Density Standard
| 79-00-5 |
|
2-Ethoxyethanol, 99%
| 110-80-5 |
|
Antimony Trichloride
| 10025-91-9 |
|
2-Ethoxyethyl acetate 99%
| 111-15-9 |
|
DL-2-Octanol, 97%
| 123-96-6 |
|
2,2,2-Trifluoroethanol
| 75-89-8 |
|
5-Amino-2-methylindole, 98%
| 7570-49-2 |
|
Bromoacetaldehyde Diethyl Acetal, 97%
| 2032-35-1 |
|
2-Acetylcyclohexanone, 97%
| 874-23-7 |
|
Lauric acid, 98%
| 143-07-7 |
|
4-Methoxy-2-nitroaniline, 98%
| 96-96-8 |
|
1-Nitroso-2-naphthol-3,6-disulfonic acid disodium salt
| 0-00-0 |
|
Toluidine Blue O Zinc Chloride Double Salt
| 0-01-1 |
|
2,4,6-Triphenylpyrylium Chloride, 90%
| 40836-01-9 |
|
2-Isopropoxyethanol, 98%
| 109-59-1 |
|
2,6-Difluorobenzoyl Isocyanate
| 60731-73-9 |
|
1-(4-Chlorophenyl)-1-Cyclopropane- Carboxylic Acid, 99%
| 72934-37-3 |
|
1-Bromo-1-propene, mixture of isomers, 95%
| 590-14-7 |
|
3-Aminopyrrolidine Dihydrochloride
| 103831-11-4 |
|
2,2,4-Trimethylpentane, p.a.
| 540-84-1 |
|
Phenyl Salicylate, 99% (UV-Vis)
| 118-55-8 |
|
MOPS
| 1132-61-2 |
|
P-Naphtholbenzein, 90+% (UV-VIS)
| 145-50-6 |
|
1-Amino-4-Hydroxyanthraquinone, 96%
| 116-85-8 |
|
4-Aminoantipyrine, 98%
| 83-07-8 |
|
Sodium metatungstate, 2.82 density solution in water, stabilized
| 7732-18-5 |
|
8-Hydroxyquinoline, p.a.
| 148-24-3 |
|
3-Methyl-2-Cyclohexen-1-One, 98%
| 1193-18-6 |
|
Cerium(IV) sulfate tetrahydrate
| 10294-42-5 |
|
Sodium metatungstate hydrate, crystalline
| 12141-67-2 |
|
O-Methylbenzyl Cyanide, 98%
| 22364-68-7 |
|
l(-)-Glutathione, oxidized, hydrate, 95%
| 27025-41-8 |
|
Antimony Trioxide
| 1309-64-4 |
|
Dibutyl L-Tartrate
| 87-92-3 |
|
(-)-Terpinen-4-ol, 97%
| 562-74-3 |
|
3,5-Dinitrosalicylic Acid Monosodium Salt, Monohydrate, 97% (Titr.)
| 46506-88-1 |
|
4-Tert.-Butyl-Calix[4]arene-Crown-4-Complex
| 171058-95-0 |
|
4-Tert.-Butyl-Calix[4]Arene-Crown-5-Complex
| 99314-01-9 |
|
4-Tert.-Butyl-Calix[4]Arene-Crown-6-Complex
| 129518-51-0 |
|
2,3,4,5-Tetrafluoro-6-nitrobenzoic acid
| 16583-08-7 |
|
|